Atara Biotherapeutics, Inc. (ATRA)

Biological Products, (No Diagnostic Substances)

Latest Price

$8.50

TTM P/E

Normalized P/E

Div Yield

Book Value

0.08

P/B Ratio

111.70

Valuation metrics

EPS: $2.57

Target P/E: 15×

Formula: EPS × P/E

P/E Fair Value

$38.55

+354% upside

46.9% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
EcoR1 Capital, LLC	1.55M	$17.0M	16.44%	+1.45M	2026-06-30
Adage Capital Partners GP, L.L.C.	850.0K	$9.0M	9.00%	+150.0K	2026-06-30
Point72 Asset Management, L.P.	687.7K	$7.0M	7.28%	+493.5K	2026-06-30
Redmile Group, LLC	441.7K	$5.0M	4.68%	--	2026-06-30
Vanguard Capital Management LLC	247.0K	$2.0M	2.62%	+29.2K	2026-06-30
Mackenzie Financial Corp	233.2K	$2.0M	2.47%	-80.4K	2026-06-30
BlackRock, Inc.	84.5K	--	0.89%	+5.4K	2026-06-30
Geode Capital Management, LLC	75.1K	--	0.80%	+9.0K	2026-06-30
Staley Capital Advisers Inc	50.0K	--	0.53%	--	2026-06-30
Vanguard Fiduciary Trust Co	43.0K	--	0.46%	+9.4K	2026-06-30